AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harry, J. B.
Right arrow Articles by White, T. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harry, J. B.
Right arrow Articles by White, T. C.
Antimicrobial Agents and Chemotherapy, July 2005, p. 2785-2792, Vol. 49, No. 7
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.7.2785-2792.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Drug-Induced Regulation of the MDR1 Promoter in Candida albicans

Jo Beth Harry,2,{dagger} Brian G. Oliver,1,2 Jia L. Song,1,2,{ddagger} Peter M. Silver,1,2 John T. Little,2,§ Jake Choiniere,2 and Theodore C. White1,2*

Department of Pathobiology, School of Public Health and Community Medicine, University of Washington,1 Seattle Biomedical Research Institute, Seattle, Washington2

Received 31 December 2004/ Returned for modification 10 March 2005/ Accepted 8 April 2005

Resistance of Candida albicans to azole antifungal drugs is mediated by two types of efflux pumps, encoded by the MDR1 gene and the CDR gene family. MDR1 mRNA levels in a susceptible clinical isolate are induced by benomyl (BEN) but not by other drugs previously shown to induce MDR1. To monitor MDR1 expression under several conditions, the MDR1 promoter was fused to the Renilla reniformis luciferase reporter gene (RLUC). The promoter was monitored for its responses to four oxidizing agents, five toxic hydrophobic compounds, and an alkylating agent, all shown to induce major facilitator pumps in other organisms. Deletion constructs of the MDR1 promoter were used to analyze the basal transcription of the promoter and its responses to the toxic compound BEN and the oxidizing agent tert-butyl hydrogen peroxide (T-BHP). The cis-acting elements in the MDR1 promoter responsible for induction by BEN were localized between –399 and –299 upstream of the start codon. The cis-acting elements responsible for MDR1 induction by T-BHP were localized between –601 and –500 upstream of the start codon. The T-BHP induction region contains a sequence that resembles the YAP1-responsive element (YRE) in Saccharomyces cerevisiae. This Candida YRE was placed upstream of a noninducible promoter in the luciferase construct, resulting in an inducible promoter. Inversion or mutation of the 7-bp YRE eliminated induction. Many of the drugs used in this analysis induce the MDR1 promoter at concentrations that inhibit cell growth. These analyses define cis-acting elements responsible for drug induction of the MDR1 promoter.


* Corresponding author. Mailing address: Seattle Biomedical Research Institute, 307 Westlake Ave., N., Suite 500, Seattle, WA 98109-5219. Phone: (206) 256-7344. Fax: (206) 256-7229. E-mail: ted.white{at}sbri.org.

{dagger} Present address: National Institute on Aging, NIH, Baltimore, Md.

{ddagger} Present address: Brown University, Providence, R.I.

§ Present address: University of California at Santa Clara, Santa Clara, Calif.


Antimicrobial Agents and Chemotherapy, July 2005, p. 2785-2792, Vol. 49, No. 7
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.7.2785-2792.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2005 by the American Society for Microbiology. All rights reserved.